We are live on ! Find out more
CGC icon

Canopy Growth

0.4270 USD
-0.0473
9.97%
At close Updated Nov 20, 4:00 PM EST
Pre-market
After hours
0.4320
+0.0050
1.17%
1 day
-9.97%
5 days
-21.51%
1 month
-40.69%
3 months
-59.33%
6 months
-58.54%
Year to date
-64.12%
1 year
-57.72%
5 years
-99.63%
10 years
-99.85%
 

About: Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Employees: 1,128

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 34.9%
Neutral 48.8%
Negative 16.3%
Negative
Zacks Investment Research
3 days ago
Cannabis Stock CGC Loses 26% in a Month: Should You Buy the Dip?
Canopy Growth's 26% monthly plunge follows disappointing earnings, but international cannabis growth and cost savings offer some positives.
Cannabis Stock CGC Loses 26% in a Month: Should You Buy the Dip?
Positive
Zacks Investment Research
9 days ago
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Positive
The Motley Fool
14 days ago
Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors
International cannabis net revenue grew 141% year over year to $12.3 million. Cultivation yields have the potential to increase 25% to 30% in the Kincardine facility.
Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors
Neutral
Seeking Alpha
15 days ago
Canopy Growth Corporation (WEED:CA) Q2 2027 Earnings Call Transcript
Canopy Growth Corporation ( WEED:CA ) Q2 2027 Earnings Call November 6, 2026 10:00 AM EST Company Participants John Vincic Luc Mongeau - CEO & Director Thomas Stewart - Chief Accounting Officer & CFO Conference Call Participants Aaron Grey - Alliance Global Partners, Research Division William Kirk - ROTH Capital Partners, LLC, Research Division Kenric Tyghe - Canaccord Genuity Corp., Research Division Frederico Yokota Gomes - ATB Cormark Capital Markets Inc., Research Division Pablo Zuanic - Zuanic & Associates Presentation Operator Good morning. My name is Joanna, and I will be your conference operator today.
Canopy Growth Corporation (WEED:CA) Q2 2027 Earnings Call Transcript
Positive
MarketBeat
15 days ago
Canopy Growth Q2 Earnings Call Highlights
Canopy Growth NASDAQ: CGC reported a 22% increase in fiscal second-quarter revenue as international cannabis sales more than doubled, and executives said the company remains on track to achieve positive adjusted EBITDA in the second half of fiscal 2027.
Canopy Growth Q2 Earnings Call Highlights
Negative
Zacks Investment Research
15 days ago
Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates
Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.01 per share a year ago.
Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates
Neutral
Business Wire
15 days ago
Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced its financial results for the three months ended September 30, 2026 ("Q2 FY2027"). All financial information in this press release is reported in Canadian dollars, unless otherwise indicated. “We have made tremendous progress on our international strategy. Our internati.
Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis
Neutral
The Motley Fool
22 days ago
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Canopy Growth (CGC -4.34%) primarily generates revenue by selling medical and recreational cannabis products to consumers across several international regions.
Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis
Positive
Zacks Investment Research
23 days ago
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Positive
Zacks Investment Research
25 days ago
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
Canopy Growth Corporation (CGC) closed the most recent trading day at $0.68, moving +2.42% from the previous trading session.
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
Price charts implemented using Lightweight Charts™